Home
NICE Guidance
Population groups
Children and young people
Explore
Register as a stakeholder
Show sections
18 new
and
5 updated
products since March 2017.
There is
1 consultation
in progress.
NICE Pathways - mapping our guidance
Antisocial behaviour and conduct disorders in children and young people
Attachment difficulties in children and young people
Attention deficit hyperactivity disorder
Autism spectrum disorder
Bacterial meningitis and meningococcal septicaemia
Bedwetting in children and young people
Blood and bone marrow cancers
Bronchiolitis in children
Cerebral palsy in under 25s
Constipation
Contraceptive services for under 25s
Depression
Developmental follow-up of children and young people born preterm
Diabetes in children and young people
Diarrhoea and vomiting in children
Diet
Dyspepsia and gastro-oesophageal reflux disease
Eating disorders
Eczema
End of life care for people with life-limiting conditions
Epilepsy
Excess winter deaths and illnesses associated with cold homes
Fever in under 5s
Food allergy in under 19s
Harmful sexual behaviour among children and young people
Immunisations for under 19s
Intravenous fluid therapy in hospital
Lifestyle weight management services for overweight or obese children and young people
Looked-after babies, children and young people
Lung cancer
Maternal and child nutrition
Myeloma
Physical activity
Postnatal care
Preventing sexually transmitted infections and under-18 conceptions
Prophylaxis against infective endocarditis
Psychosis and schizophrenia
Sedation in children and young people
Sepsis
Smoking
Social and emotional wellbeing for children and young people
Spasticity in children and young people
Surgical management of otitis media with effusion in children
Suspected cancer recognition and referral
Transient loss of consciousness
Transition from children's to adults' services
Unintentional injuries among under-15s
Urinary tract infection in under 16s
When to suspect child maltreatment
NICE
Evidence summaries
Acute diarrhoea in children: racecadotril as an adjunct to oral rehydration
(ESNM12)
March 2013
Attention deficit hyperactivity disorder in children and young people: clonidine
(ESUOM8)
April 2013
Attention deficit hyperactivity disorder in children and young people: guanfacine prolonged-release
(ESNM70)
March 2016
Attention deficit hyperactivity disorder in children and young people: lisdexamfetamine dimesylate
(ESNM19)
May 2013
Management of vomiting in children and young people with gastroenteritis: ondansetron
(ESUOM34)
October 2014
Mitochondrial disorders in children: Co-enzyme Q10
(ES11)
March 2017
Partial seizures in children and young people with epilepsy: zonisamide as adjunctive therapy
(ESNM37)
March 2014
Promoting tolerance of enteral feeds in children and young people: domperidone
(ESUOM18)
July 2013
Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide
(ES5)
February 2017
Sleep disorders in children and young people with attention deficit hyperactivity disorder: melatonin
(ESUOM2)
January 2013
Technology appraisal guidance
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
(TA455)
July 2017
Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years
(TA213)
January 2011
Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder
(TA292)
July 2013
Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal)
(TA302)
November 2013
Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma
(TA10)
August 2000
Human growth hormone (somatropin) for the treatment of growth failure in children
(TA188)
May 2010
Immunosuppressive therapy for renal transplantation in children and adolescents
(TA99)
April 2006
Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years
(TA131)
November 2007
Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years)
(TA38)
March 2002
Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
(TA98)
March 2006
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
(TA300)
November 2013
Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
(TA238)
December 2011
Quality standards
Antisocial behaviour and conduct disorders in children and young people
(QS59)
April 2014
Atopic eczema in under 12s
(QS44)
September 2013
Bedwetting in children and young people
(QS70)
September 2014
Bipolar disorder, psychosis and schizophrenia in children and young people
(QS102)
October 2015
Bronchiolitis in children
(QS122)
June 2016
Cancer services for children and young people
(QS55)
February 2014
Children’s attachment
(QS133)
October 2016
Constipation in children and young people
(QS62)
May 2014
Depression in children and young people
(QS48)
September 2013
Diabetes in children and young people
(QS125)
July 2016
Early years: promoting health and wellbeing in under 5s
(QS128)
August 2016
End of life care for infants, children and young people
(QS160)
September 2017
Epilepsy in children and young people
(QS27)
February 2013
Fever in under 5s
(QS64)
July 2014
Food allergy
(QS118)
March 2016
Gastro-oesophageal reflux in children and young people
(QS112)
January 2016
Haematological cancers
(QS150)
June 2017
Headaches in over 12s
(QS42)
August 2013
Intravenous fluid therapy in children and young people in hospital
(QS131)
September 2016
Looked-after children and young people
(QS31)
April 2013
Maternal and child nutrition
(QS98)
July 2015
Meningitis (bacterial) and meningococcal septicaemia in children and young people
(QS19)
June 2012
Obesity in children and young people: prevention and lifestyle weight management programmes
(QS94)
July 2015
Obesity: clinical assessment and management
(QS127)
August 2016
Preventing unintentional injury in under 15s
(QS107)
January 2016
Suspected cancer
(QS124)
June 2016
Transition from children’s to adults’ services
(QS140)
December 2016
Urinary tract infection in children and young people
(QS36)
July 2013
Vaccine uptake in under 19s
(QS145)
March 2017
NICE
Guidelines
Antisocial behaviour and conduct disorders in children and young people: recognition and management
(CG158)
March 2013
Atopic eczema in under 12s: diagnosis and management
(CG57)
December 2007
Attention deficit hyperactivity disorder: diagnosis and management
(CG72)
September 2008
Autism spectrum disorder in under 19s: recognition, referral and diagnosis
(CG128)
September 2011
Autism spectrum disorder in under 19s: support and management
(CG170)
August 2013
Bedwetting in under 19s
(CG111)
October 2010
Bronchiolitis in children: diagnosis and management
(NG9)
June 2015
Cerebral palsy in under 25s: assessment and management
(NG62)
January 2017
Child maltreatment: when to suspect maltreatment in under 18s
(CG89)
July 2009
Children’s attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care
(NG26)
November 2015
Constipation in children and young people: diagnosis and management
(CG99)
May 2010
Contraceptive services for under 25s
(PH51)
March 2014
Depression in children and young people: identification and management
(CG28)
September 2005
Developmental follow-up of children and young people born preterm
(NG72)
August 2017
Diabetes (type 1 and type 2) in children and young people: diagnosis and management
(NG18)
August 2015
Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management
(CG84)
April 2009
Eating disorders: recognition and treatment
(NG69)
May 2017
End of life care for infants, children and young people with life-limiting conditions: planning and management
(NG61)
December 2016
Epilepsies: diagnosis and management
(CG137)
January 2012
Excess winter deaths and illness and the health risks associated with cold homes
(NG6)
March 2015
Fever in under 5s: assessment and initial management
(CG160)
May 2013
Food allergy in under 19s: assessment and diagnosis
(CG116)
February 2011
Gastro-oesophageal reflux disease in children and young people: diagnosis and management
(NG1)
January 2015
Harmful sexual behaviour among children and young people
(NG55)
September 2016
Immunisations: reducing differences in uptake in under 19s
(PH21)
September 2009
Improving outcomes in children and young people with cancer
(CSG7)
August 2005
Intravenous fluid therapy in children and young people in hospital
(NG29)
December 2015
Looked-after children and young people
(PH28)
October 2010
Maternal and child nutrition
(PH11)
March 2008
Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management
(CG102)
June 2010
Otitis media with effusion in under 12s: surgery
(CG60)
February 2008
Physical activity for children and young people
(PH17)
January 2009
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures
(CG64)
March 2008
Psychosis and schizophrenia in children and young people: recognition and management
(CG155)
January 2013
Sedation in under 19s: using sedation for diagnostic and therapeutic procedures
(CG112)
December 2010
Sexually transmitted infections and under-18 conceptions: prevention
(PH3)
February 2007
Smoking prevention in schools
(PH23)
February 2010
Smoking: preventing uptake in children and young people
(PH14)
July 2008
Social and emotional wellbeing in secondary education
(PH20)
September 2009
Social and emotional wellbeing: early years
(PH40)
October 2012
Spasticity in under 19s: management
(CG145)
July 2012
Suspected cancer: recognition and referral
(NG12)
June 2015
Transient loss of consciousness ('blackouts') in over 16s
(CG109)
August 2010
Transition from children’s to adults’ services for young people using health or social care services
(NG43)
February 2016
Unintentional injuries in the home: interventions for under 15s
(PH30)
November 2010
Unintentional injuries on the road: interventions for under 15s
(PH31)
November 2010
Unintentional injuries: prevention strategies for under 15s
(PH29)
November 2010
Urinary tract infection in under 16s: diagnosis and management
(CG54)
August 2007
Weight management: lifestyle services for overweight or obese children and young people
(PH47)
October 2013
Highly specialised technologies guidance
Asfotase alfa for treating paediatric-onset hypophosphatasia
(HST6)
August 2017
Interventional procedures guidance
Balloon dilatation of systemic to pulmonary arterial shunts in children
(IPG77)
July 2004
Balloon dilatation with or without stenting for pulmonary artery or non-valvar right ventricular outflow tract obstruction in children
(IPG76)
July 2004
Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children
(IPG232)
September 2007
Vagus nerve stimulation for refractory epilepsy in children
(IPG50)
March 2004
NICE
Local government briefings
Health visiting
(LGB22)
September 2014
Looked-after children and young people
(LGB19)
June 2014
Social and emotional wellbeing for children and young people
(LGB12)
September 2013
NICE
Medtech innovation briefings
Mollii suit for spasticity
(MIB100)
March 2017
Medical technologies guidance
The MAGEC system for spinal lengthening in children with scoliosis
(MTG18)
June 2014
In development
Attention deficit hyperactivity disorder (update)
(GID-CGWAVE0798)
February 2018
NICE guidelines
Cerebral palsy in children and young people
(GID-QS10044)
October 2017
Quality standards
Child abuse and neglect
(GID-QS10054)
July 2018
Quality standards
Child abuse and neglect
(GID-SCWAVE0708)
October 2017
NICE guidelines
Children and young people with severe complex needs: social care support
(GID-NG10048)
TBC
NICE guidelines
Faltering growth - recognition and management of faltering growth in children
(GID-CGWAVE0767)
September 2017
NICE guidelines
Kidney transplantation (children, adolescents) - immunosuppressive regimens (review of TA99) [ID346]
(GID-TAG255)
October 2017
Technology appraisal guidance
Levitronix CentriMag for treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency in adult and paediatric patients
(GID-MT130)
TBC
Medical technologies guidance
Neuroblastoma (high risk) - APN311 [ID910]
(GID-TA10069)
May 2018
Technology appraisal guidance
Urinary tract infection in under 16s (standing committee update)
(GID-NG10038)
September 2017
NICE guidelines
Guidance
Resources
Savings and productivity
Local practice